Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $671.9900 (-0.85%) ($671.9900 - $681.7400) on Tue. Aug. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.36% (three month average) | RSI | 79 | Latest Price | $671.9900(-0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 3.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(41%) DIA(37%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.68% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-6%) VXX(-5%) IGOV(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.68% (StdDev 1.36%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $669.71(0.34%) | 10 Day Moving Average | $664.85(1.07%) | 20 Day Moving Average | $640.86(4.86%) | To recent high | -0.8% | To recent low | 33.9% | Market Cap | $71.25b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |